Peter S. Freudenthal

Mr. Peter S.
Freudenthal is Co-Founder & Managing General Partner at Darwin Ventures LLC.
Mr. Freudenthal founded Darwin Ventures in 2002.
Most recently he was Chairman, CEO and Founder of meVC, Inc. Prior to founding meVC in 1999, Mr. Freudenthal was Senior Biotechnology Equity Research Analyst and a Vice President with Robertson Stephens & Company in San Francisco.
From 1995 until 1997, he was Director of Healthcare Research at Brean Murray & Company, a privately held investment bank in New York.
He was a National Science Foundation Fellow (1986-1990), a David C.
Scott Foundation Fellow (1987-1990), and a member of the NY Academy of Science.
From 1981 to 1985, he was a Thomas J.
Watson Scholar at the IBM Research Center in Yorktown, New York.
Mr. Freudenthal received his BS from Yale University with a double major with distinction in molecular biophysics and biochemistry and molecular biology in 1985.
Mr. Freudenthal attended the Yale School of Medicine where he focused on neurosurgery and trama surgery.
Before medical school, he was a senior graduate fellow in the Laboratory of Immunology & Cellular Physiology at The Rockefeller University of New York.